FRBRX Mutual Fund

FRBRX Mutual Fund (Franklin Biotechnology Discovery Fund Class R6) is managed by Franklin Templeton Investments (US) with $6.2M in net assets. FRBRX expense ratio is 0.67%, holding 120 positions across sectors including Health Care, Financials. Inception date: 2013-05-01.

FRBRX performance shows a YTD return of 12.13%. The 1-year return is 21.62% and the 5-year return is 11.40%. FRBRX dividend yield stands at 1.99%, paid annually.

FRBRX top holdings include Jazz Pharmaceuticals Plc. (5.7%), Amgen Inc. (4.4%), Gilead Sciences (3.9%), Regeneron Pharmaceuticals, Inc. (3.8%), Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) (3.6%). Go to all FRBRX holdings, FRBRX sectors, or FRBRX dividends.

FRBRX can be compared against other funds. Use FRBRX overlap to find shared positions, or FRBRX vs another fund for a side-by-side view. FRBRX alternatives are available via the screener, along with tax-loss harvesting opportunities.